---
title: "AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery"
date: "2024-11-19T11:18:08.000Z"
publishedDate: "19 novembre 2024"
summary: "Edoxaban may be an effective alternative to warfarin—the current standard of care—for patients undergoing bioprosthetic valve surgery, new research has shown. Chisato Izumi (National Cerebral and Cardiovascular Center, Suita, Japan) presented findings of the ENBALV trial, in which researchers compared edoxaban to warfarin in 410 patients undergoing aortic or mitral valve replacement surgery at 24 [&#8230;] The post AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/aha-2024-edoxaban-warfarin-enbalv/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-11-19-aha-2024-edoxaban-an-effective-alternative-to-warfarin-following-valve-replacement-surgery"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/11/ChisatoIzumiM.D.Ph_edited1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/aha-2024-edoxaban-warfarin-enbalv/"
---

![AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/11/ChisatoIzumiM.D.Ph_edited1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/aha-2024-edoxaban-warfarin-enbalv/*

## L’essentiel

Edoxaban may be an effective alternative to warfarin—the current standard of care—for patients undergoing bioprosthetic valve surgery, new research has shown. Chisato Izumi (National Cerebral and Cardiovascular Center, Suita, Japan) presented findings of the ENBALV trial, in which researchers compared edoxaban to warfarin in 410 patients undergoing aortic or mitral valve replacement surgery at 24 [&#8230;] The post AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/aha-2024-edoxaban-warfarin-enbalv/
